Table 1.
Adverse Event | Any Grade | High Grade* | P-value† | |||
---|---|---|---|---|---|---|
Arm A (N=100) |
Arm B (N=100) |
Arm A (N=100) |
Arm B (N=100) |
|||
Anorexia | Clinician | 43 (43%) | 36 (36%) | 3 (3%) | 2 (2%) | 0.39 |
Patient | 57 (57%) | 40 (40%) | 11 (11%) | 8 (8%) | 0.02 | |
Constipation | Clinician | 27 (27%) | 23 (23%) | 1 (1%) | -- | 0.62 |
Patient | 48 (48%) | 41 (41%) | 12 (12%) | 7 (7%) | 0.39 | |
Diarrhea | Clinician | 8 (8%) | 14 (14%) | 1 (1%) | -- | 0.26 |
Patient | 39 (39%) | 12 (12%) | 4 (4%) | -- | <0.001 | |
Nausea | Clinician | 20 (20%) | 7 (7%) | -- | -- | 0.01 |
Patient | 66 (66%) | 9 (9%) | 9 (9%) | 1 (1%) | <0.001 | |
Sensory neuropathy | Clinician | 54 (54%) | 29 (29%) | 7 (7%) | 4 (4%) | <0.001 |
Patient | 59 (59%) | 51 (51%) | 3 (3%) | -- | 0.32 |
Grade >3 based on Common Terminology Criteria for Adverse Events (CTCAE).
Based on Fisher’s exact test comparing rate of grade >0 between arms.